Share-based Payment Arrangement, Expense of Bausch Health Companies Inc. from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bausch Health Companies Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • Bausch Health Companies Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $84,000,000, a 95% increase year-over-year.
  • Bausch Health Companies Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $216,000,000, a 44% increase year-over-year.
  • Bausch Health Companies Inc. annual Share-based Payment Arrangement, Expense for 2025 was $216,000,000, a 44% increase from 2024.
  • Bausch Health Companies Inc. annual Share-based Payment Arrangement, Expense for 2024 was $150,000,000, a 14% increase from 2023.
  • Bausch Health Companies Inc. annual Share-based Payment Arrangement, Expense for 2023 was $132,000,000, a 4.8% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Bausch Health Companies Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $216,000,000 $84,000,000 +$41,000,000 +95% 01 Oct 2025 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q3 2025 $175,000,000 $43,000,000 +$5,000,000 +13% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $170,000,000 $46,000,000 +$10,000,000 +28% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $160,000,000 $43,000,000 +$10,000,000 +30% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $150,000,000 $43,000,000 +$14,000,000 +48% 01 Oct 2024 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q3 2024 $136,000,000 $38,000,000 +$9,000,000 +31% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025 2025 Q3
Q2 2024 $127,000,000 $36,000,000 +$3,000,000 +9.1% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025 2025 Q2
Q1 2024 $124,000,000 $33,000,000 -$8,000,000 -20% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $132,000,000 $29,000,000 -$6,000,000 -17% 01 Oct 2023 31 Dec 2023 10-K 19 Feb 2026 2025 FY
Q3 2023 $138,000,000 $29,000,000 -$4,000,000 -12% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 $142,000,000 $33,000,000 +$7,000,000 +27% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024 2024 Q2
Q1 2023 $135,000,000 $41,000,000 +$9,000,000 +28% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 $126,000,000 $35,000,000 01 Oct 2022 31 Dec 2022 10-K 20 Feb 2025 2024 FY
Q3 2022 $33,000,000 $0 0% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $26,000,000 -$5,000,000 -16% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $32,000,000 +$1,000,000 +3.2% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q3 2021 $33,000,000 +$6,000,000 +22% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $31,000,000 +$4,000,000 +15% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $31,000,000 +$4,000,000 +15% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q3 2020 $27,000,000 +$1,000,000 +3.8% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $27,000,000 $0 0% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021 2021 Q2
Q1 2020 $27,000,000 +$3,000,000 +12% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q3 2019 $26,000,000 +$4,000,000 +18% 01 Jul 2019 30 Sep 2019 10-Q 03 Nov 2020 2020 Q3
Q2 2019 $27,000,000 +$5,000,000 +23% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $24,000,000 +$3,000,000 +14% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q3 2018 $22,000,000 +$3,000,000 +16% 01 Jul 2018 30 Sep 2018 10-Q 04 Nov 2019 2019 Q3
Q2 2018 $22,000,000 -$1,000,000 -4.3% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2019 Q2
Q1 2018 $21,000,000 -$7,000,000 -25% 01 Jan 2018 31 Mar 2018 10-Q 06 May 2019 2019 Q1
Q3 2017 $19,000,000 -$18,000,000 -49% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018 2018 Q3
Q2 2017 $23,000,000 -$10,000,000 -30% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $28,000,000 -$36,000,000 -56% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q3 2016 $117,600,000 $37,000,000 -$13,500,000 -27% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $131,100,000 $33,000,000 +$7,100,000 +27% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $124,000,000 $64,000,000 +$29,000,000 +83% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q4 2015 $95,000,000 $16,400,000 +$4,200,000 +20% 01 Oct 2015 31 Dec 2015 10-K 29 Apr 2016 2015 FY
Q3 2015 $90,800,000 $50,500,000 +$30,300,000 +150% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $60,500,000 $25,900,000 +$10,300,000 +66% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2
Q1 2015 $50,200,000 $35,000,000 +$10,200,000 +41% 01 Jan 2015 31 Mar 2015 10-Q 07 Jun 2016 2016 Q1
Q4 2014 $40,000,000 $20,600,000 -$34,100,000 -253% 01 Oct 2014 31 Dec 2014 10-K 29 Apr 2016 2015 FY
Q3 2014 $74,100,000 $20,200,000 +$4,200,000 +26% 01 Jul 2014 30 Sep 2014 10-Q 26 Oct 2015 2015 Q3
Q2 2014 $69,900,000 $15,600,000 +$8,200,000 +111% 01 Apr 2014 30 Jun 2014 10-Q 28 Jul 2015 2015 Q2
Q1 2014 $61,700,000 $24,800,000 +$15,700,000 +173% 01 Jan 2014 31 Mar 2014 10-Q 30 Apr 2015 2015 Q1
Q4 2013 $46,000,000 $13,500,000 +$155,000 +1.2% 01 Oct 2013 31 Dec 2013 10-K 29 Apr 2016 2015 FY
Q3 2013 $45,845,000 $16,000,000 -$2,547,000 -14% 01 Jul 2013 30 Sep 2013 10-Q 24 Oct 2014 2014 Q3
Q2 2013 $48,392,000 $7,400,000 -$7,756,000 -51% 01 Apr 2013 30 Jun 2013 10-Q 01 Aug 2014 2014 Q2
Q1 2013 $56,148,000 $9,100,000 -$10,052,000 -52% 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014 2014 Q1
Q4 2012 $66,200,000 $13,345,000 -$7,640,000 -36% 01 Oct 2012 31 Dec 2012 10-K 25 Feb 2015 2014 FY
Q3 2012 $73,840,000 $18,547,000 +$960,000 +5.5% 01 Jul 2012 30 Sep 2012 10-Q 01 Nov 2013 2013 Q3
Q2 2012 $72,880,000 $15,156,000 -$10,402,000 -41% 01 Apr 2012 30 Jun 2012 10-Q 07 Aug 2013 2013 Q2
Q1 2012 $83,282,000 $19,152,000 -$10,741,000 -36% 01 Jan 2012 31 Mar 2012 10-Q 03 May 2013 2013 Q1
Q4 2011 $94,023,000 $20,985,000 01 Oct 2011 31 Dec 2011 10-K 28 Feb 2014 2013 FY
Q3 2011 $17,587,000 -$50,697,000 -74% 01 Jul 2011 30 Sep 2011 10-Q 05 Nov 2012 2012 Q3
Q2 2011 $25,558,000 +$23,663,000 +1249% 01 Apr 2011 30 Jun 2011 10-Q 03 Aug 2012 2012 Q2
Q1 2011 $29,893,000 01 Jan 2011 31 Mar 2011 10-Q 04 May 2012 2012 Q1
Q3 2010 $68,284,000 01 Jul 2010 30 Sep 2010 10-Q 04 Nov 2011 2011 Q3
Q2 2010 $1,895,000 01 Apr 2010 30 Jun 2010 10-Q 08 Aug 2011 2011 Q2

Bausch Health Companies Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $216,000,000 +$66,000,000 +44% 01 Jan 2025 31 Dec 2025 10-K 19 Feb 2026 2025 FY
2024 $150,000,000 +$18,000,000 +14% 01 Jan 2024 31 Dec 2024 10-K 19 Feb 2026 2025 FY
2023 $132,000,000 +$6,000,000 +4.8% 01 Jan 2023 31 Dec 2023 10-K 19 Feb 2026 2025 FY
2022 $126,000,000 01 Jan 2022 31 Dec 2022 10-K 20 Feb 2025 2024 FY
2015 $95,000,000 +$55,000,000 +138% 01 Jan 2015 31 Dec 2015 10-K 29 Apr 2016 2015 FY
2014 $40,000,000 -$6,000,000 -13% 01 Jan 2014 31 Dec 2014 10-K 29 Apr 2016 2015 FY
2013 $46,000,000 -$20,200,000 -31% 01 Jan 2013 31 Dec 2013 10-K 29 Apr 2016 2015 FY
2012 $66,200,000 -$27,823,000 -30% 01 Jan 2012 31 Dec 2012 10-K 25 Feb 2015 2014 FY
2011 $94,023,000 -$4,010,000 -4.1% 01 Jan 2011 31 Dec 2011 10-K 28 Feb 2014 2013 FY
2010 $98,033,000 01 Jan 2010 31 Dec 2010 10-K 28 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.